Works matching IS 11732563 AND DT 2018 AND VI 38 AND IP 2
1
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 157, doi. 10.1007/s40261-017-0594-0
- Lancia, Pauline;
- Aurich, Beate;
- Ha, Phuong;
- Maisin, Anne;
- Baudouin, Véronique;
- Jacqz-Aigrain, Evelyne
- Article
2
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 87, doi. 10.1007/s40261-017-0592-2
- Vieta, Eduard;
- Montes, José Manuel
- Article
3
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 173, doi. 10.1007/s40261-017-0597-x
- Mennini, Francesco Saverio;
- Fabiano, Gianluca;
- Marcellusi, Andrea;
- Sciattella, Paolo;
- Saia, Mario;
- Cocchio, Silvia;
- Baldo, Vincenzo
- Article
4
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 101, doi. 10.1007/s40261-017-0596-y
- Azevedo, Alexandra;
- Torres, Tiago
- Article
5
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 113, doi. 10.1007/s40261-017-0595-z
- D’Alonzo, Renato;
- Rigante, Donato;
- Mencaroni, Elisabetta;
- Esposito, Susanna
- Article
6
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 181, doi. 10.1007/s40261-017-0600-6
- Suchkov, Igor A.;
- Martinez-Gonzalez, Javier;
- Schellong, Sebastian M.;
- Garbade, Toni;
- Falciani, Michela;
- The Bemiparin DVT Study Group
- Article
7
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 147, doi. 10.1007/s40261-017-0590-4
- Barrio, Pablo;
- Ortega, Lluisa;
- Guardia, Josep;
- Roncero, Carlos;
- Yuguero, Lara;
- Gual, Antoni
- Article
8
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 135, doi. 10.1007/s40261-017-0589-x
- Smith, Ioana;
- Schmidt, Robert;
- Halm, Ethan A.;
- Mansi, Ishak A.
- Article
9
- Clinical Drug Investigation, 2018, v. 38, n. 2, p. 125, doi. 10.1007/s40261-017-0588-y
- Zhou, Wenjia;
- Lv, Chengzhe;
- Zhang, Quanying;
- Zong, Shunlin;
- Wang, Meng
- Article